
Shire will pay a fine of $56.5 million to resolve a string of legal allegations in the US surrounding the …

Shire has posted a set of healthy financials for the second quarter, buoyed by its ADHD and rare drug portfolio. …

US regulators have delivered a blow to Shire by allowing Actavis Group to produce a generic version of its hyperactivity …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer

